A Phase 2 in Adult Subjects With Hereditary Angioedema

NCT06846398 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Hereditary Angioedema (HAE)

Interventions

DRUG: BW-20805
DRUG: BW-20805
DRUG: BW-20805

Sponsor

Shanghai Argo Biopharmaceutical Co., Ltd.